Laura Videla

2.8k total citations · 1 hit paper
30 papers, 561 citations indexed

About

Laura Videla is a scholar working on Public Health, Environmental and Occupational Health, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Laura Videla has authored 30 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 12 papers in Psychiatry and Mental health and 8 papers in Physiology. Recurrent topics in Laura Videla's work include Down syndrome and intellectual disability research (16 papers), Dementia and Cognitive Impairment Research (11 papers) and Frailty in Older Adults (7 papers). Laura Videla is often cited by papers focused on Down syndrome and intellectual disability research (16 papers), Dementia and Cognitive Impairment Research (11 papers) and Frailty in Older Adults (7 papers). Laura Videla collaborates with scholars based in Spain, United States and United Kingdom. Laura Videla's co-authors include Juan Fortea, Alberto Lleó, María Carmona‐Iragui, Daniel Alcolea, Jordi Pegueroles, Rafael Blesa, Olivia Belbin, Víctor Montal, Jordi Clarimón and Bessy Benejam and has published in prestigious journals such as Nature Medicine, Neurology and Diabetes Care.

In The Last Decade

Laura Videla

24 papers receiving 554 citations

Hit Papers

APOE4 homozygosity represents a distinct genetic form of ... 2024 2026 2025 2024 40 80 120

Peers

Laura Videla
Dawn C. Matthews United States
Randolph D. Andrews United States
Karly Alex Cody United States
Anette Hall Finland
Auttawut Roontiva United States
Jean K. Ho United States
Ryan Townley United States
Laura Videla
Citations per year, relative to Laura Videla Laura Videla (= 1×) peers Isabel Barroeta

Countries citing papers authored by Laura Videla

Since Specialization
Citations

This map shows the geographic impact of Laura Videla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Videla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Videla more than expected).

Fields of papers citing papers by Laura Videla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Videla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Videla. The network helps show where Laura Videla may publish in the future.

Co-authorship network of co-authors of Laura Videla

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Videla. A scholar is included among the top collaborators of Laura Videla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Videla. Laura Videla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kac, Przemysław R., Daniel Alcolea, Laia Montoliu‐Gaya, et al.. (2025). Plasma p‐tau212 as a biomarker of sporadic and Down syndrome Alzheimer's disease. Alzheimer s & Dementia. 21(4). e70172–e70172. 3 indexed citations
2.
Ledreux, Aurélie, María Carmona‐Iragui, Laura Videla, et al.. (2025). Cargo of small extracellular vesicles from neuronal origin shows progression of dementia in individuals with Down syndrome. Alzheimer s & Dementia. 21(6). e70380–e70380.
3.
Alcolea, Daniel, Laia Montoliu‐Gaya, María Carmona‐Iragui, et al.. (2024). Longitudinal plasma and CSF analyses in Down syndrome. Results from the DABNI cohort. Alzheimer s & Dementia. 20(S2).
4.
Fortea, Juan, Jordi Pegueroles, Daniel Alcolea, et al.. (2024). APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease. Nature Medicine. 30(5). 1284–1291. 140 indexed citations breakdown →
5.
Benejam, Bessy, Lídia Vaqué‐Alcázar, Valle Camacho, et al.. (2024). Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome. Neurology. 104(1). e210179–e210179. 1 indexed citations
6.
Pané, Adriana, Laura Videla, Judith Viaplana, et al.. (2024). Hypothalamic Inflammation Improves Through Bariatric Surgery, and Hypothalamic Volume Predicts Short-Term Weight Loss Response in Adults With or Without Type 2 Diabetes. Diabetes Care. 47(7). 1162–1170. 3 indexed citations
7.
Vaqué‐Alcázar, Lídia, María Carmona‐Iragui, Laura Videla, et al.. (2023). Cognitive reserve in Down syndrome: a new opportunity to understand resilience in Alzheimer’s disease. Alzheimer s & Dementia. 19(S23).
8.
Pegueroles, Jordi, Valle Camacho, Víctor Montal, et al.. (2023). [18F]PI2620 tau deposition increases along the Alzheimer’s disease continuum in Down Syndrome and in presence of amyloid. Alzheimer s & Dementia. 19(S21). 1 indexed citations
9.
Belbin, Olivia, M. Florencia Iulita, Laura Videla, et al.. (2023). Biofluid markers of Alzheimer’s disease‐associated CNS inflammation in adults with Down syndrome. Alzheimer s & Dementia. 19(S14).
10.
Giménez, Sandra, Laura Videla, Marta Gutiérrez‐Valencia, et al.. (2022). Feasibility and Long-Term Compliance to Continuous Positive Airway Pressure Treatment in Adults With Down Syndrome, a Genetic Form of Alzheimer’s Disease. Frontiers in Neuroscience. 16. 838412–838412. 2 indexed citations
11.
Montal, Víctor, Isabel Barroeta, Alexandre Bejanin, et al.. (2021). Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome. Annals of Neurology. 90(3). 407–416. 10 indexed citations
12.
Carmona‐Iragui, María, Laura Videla, Bessy Benejam, et al.. (2021). Neuropsychological correlates of plasma NfL in adults with Down syndrome. Alzheimer s & Dementia. 17(S4).
13.
Benejam, Bessy, Laura Videla, Eduard Vilaplana, et al.. (2020). Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 12(1). e12047–e12047. 31 indexed citations
14.
Gonzalo‐Calvo, David de, Isabel Barroeta, María Carmona‐Iragui, et al.. (2020). Evaluation of biochemical and hematological parameters in adults with Down syndrome. Scientific Reports. 10(1). 13755–13755. 3 indexed citations
15.
Belbin, Olivia, Desheng Xu, María Carmona‐Iragui, et al.. (2020). Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer’s disease-related inhibitory circuit dysfunction in adults with Down syndrome. Molecular Neurodegeneration. 15(1). 46–46. 24 indexed citations
16.
Carmona‐Iragui, María, Laura Videla, Alberto Lleó, & Juan Fortea. (2019). Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosis. Developmental Neurobiology. 79(7). 716–737. 38 indexed citations
17.
Fortea, Juan, María Carmona‐Iragui, Bessy Benejam, et al.. (2018). Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. The Lancet Neurology. 17(10). 860–869. 124 indexed citations
19.
Fortea, Juan, María Carmona‐Iragui, Susana Fernández, et al.. (2016). O5‐02‐04: DOWN ALZHEIMER BARCELONA NEUROIMAGING INITIATIVE (DABNI): A PROSPECTIVE LONGITUDINAL BIOMARKER COHORT TO STUDY ALZHEIMER’S DISEASE IN DOWN SYNDROME. Alzheimer s & Dementia. 12(7S_Part_7). 4 indexed citations
20.
Benejam, Bessy, Laura Videla, Susana Fernández, et al.. (2014). P4‐320: NEUROPSYCHOLOGICAL ASSESSMENT OF ADULTS WITH DOWN SYNDROME USING THE CAMCOG‐DS: A LONGITUDINAL COHORT STUDY. Alzheimer s & Dementia. 10(4S_Part_16). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026